### About
Erik Reinertsen is the Director of Data Science & Engineering at Prometheus Biosciences. He led digital strategy spanning multimodal data curation, bioinformatics pipelines, and machine learning. His team contributed to a successful phase 2 study in IBD, an IND application, new companion diagnostics, and indication expansion decisions. Currently, he is analyzing cell subtypes in inflammation using histopathology, gene expression, and deep learning.

Prior, Erik was a postdoctoral fellow at Massachusetts General Hospital, Massachusetts Institute of Technology, and the Broad Institute where he developed deep learning models to predict outcomes from high-resolution physiological and clinical data. He also evaluated computational drug discovery startups at Takeda Ventures.

Erik received an MD from Emory University, and a PhD in Biomedical Engineering with a minor in Statistics from Georgia Institute of Technology where he worked on signal processing and ML methods. In graduate school, he co-founded Forge Health, a non-profit that provided startups with funding, mentors, and assistance starting pilot studies. Erik earned a BS in Bioengineering from UCLA and serves on the Department of Bioengineering's Alumni Advisory Board.

### Blog Posts
[New job at Prometheus](/posts/prometheus.md)  
[How to give a great chalk talk](/posts/chalk-talk.md)  
[Forge merges with Sling Health](/posts/forge.md)  
[My interview for the Hertz Fellowship](/posts/hertz-interview.md)  
[Tips for new TAs](/posts/tips-for-taing.md)  
[The GT BME PhD qualifying exam](/posts/gtbme-quals.md)  
[Write a great personal statement for medical school](/posts/ps.md)  
[Make $43K by not paying your medical school debt](/posts/roth.md)  
[Tips for new researchers](/posts/tips-for-researchers.md)
